BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baksmeier C, Blundell P, Steckel J, Schultz V, Gu Q, Da Silva Filipe A, Kohl A, Linnington C, Lu D, Dell A, Haslam S, Wang J, Czajkowsky D, Goebels N, Pleass RJ. Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination. Immunology 2021;164:90-105. [PMID: 33880776 DOI: 10.1111/imm.13341] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Vattepu R, Sneed SL, Anthony RM. Sialylation as an Important Regulator of Antibody Function. Front Immunol 2022;13:818736. [PMID: 35464485 DOI: 10.3389/fimmu.2022.818736] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pleass RJ. The therapeutic potential of sialylated Fc domains of human IgG. MAbs 2021;13:1953220. [PMID: 34288809 DOI: 10.1080/19420862.2021.1953220] [Cited by in F6Publishing: 2] [Reference Citation Analysis]